ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

NCI STRAP Grants Aim To Move Research Quickly To Clinical Trials

October 1, 2010

In Brief: House Budget Committee Proposes 5% Cut To NIH In FY96; Steady Reductions Expected

March 24, 1995

Obituary: Emmanuel Farber, Experimental Pathologist, Dies at Age 95

August 8, 2014

In Brief: Reagan/Congress Budget Compromise Seems Likely, Would Loosen FY 1982 Spending Limits On NCI

December 11, 1981

Varmus’s 2016 Bypass Budget Seeks “Modest” Increase of $823 Million

December 5, 2014

NCAB Committee Submits Drafts Of QRA Policy Statement

July 8, 1983